Can we skip weekends in GnRH antagonist cycles without compromising the final outcome?
The author discusses the challenges in programming GnRH antagonist cycles.
Published
Authors
Ernesto Bosch, M.D.
Vol 97, Issue 6 , Pages 1299-1300
Abstract
Gonadotropin-releasing hormone (GnRH) antagonists were introduced into clinical practice more than a decade ago. However, although they offer a number of advantages compared with GnRH agonists, their introduction in daily practice has been slower than initially could be expected. A major drawback for their consolidation has been the limitation for programming cycles, as when the GnRH antagonist protocol gonadotropin administration is started on day 2 or 3 of menses, which is clearly an unpredictable event.
Read the full text at: http://www.fertstert.org/article/S0015-0282(12)00479-7/fulltext
